key: cord-0771157-nk4ppgtk authors: Stoicescu, Emil Robert; Ciuca, Ioana Mihaiela; Iacob, Roxana; Iacob, Emil Radu; Marc, Monica Steluta; Birsasteanu, Florica; Manolescu, Diana Luminita; Iacob, Daniela title: Is Lung Ultrasound Helpful in COVID-19 Neonates?—A Systematic Review date: 2021-12-08 journal: Diagnostics (Basel) DOI: 10.3390/diagnostics11122296 sha: 998febb87272327602a800a693689335e08cf79a doc_id: 771157 cord_uid: nk4ppgtk Background: The SARS-CoV-2 infection has occurred in neonates, but it is a fact that radiation exposure is not recommended given their age. The aim of this review is to assess the evidence on the utility of lung ultrasound (LUS) in neonates diagnosed with COVID-19. Methods: A systematic literature review was performed so as to find a number of published studies assessing the benefits of lung ultrasound for newborns diagnosed with COVID and, in the end, to make a comparison between LUS and the other two more conventional procedures of chest X-rays or CT exam. The key terms used in the search of several databases were: “lung ultrasound”, “sonography”, “newborn”, “neonate”, and “COVID-19′. Results: In total, 447 studies were eligible for this review, and after removing the duplicates, 123 studies referring to LU were further examined, but only 7 included cases of neonates. These studies were considered for the present research paper. Conclusions: As a non-invasive, easy-to-use, and reliable method for lung lesion detection in neonates with COVID-19, lung ultrasound can be used as a useful diagnosis tool for the evaluation of COVID-19-associated lung lesions. The benefits of this method in this pandemic period are likely to arouse interest in opening new research horizons, with immediate practical applicability. From the beginning of the pandemic until now, over 250 million cases of SARS-CoV-2 infections have been reported, according to the Worldometer website [1] . Out of these, a limited number of approximately 15% of cases are infections among children, infants, and newborns, according to the latest data provided by the American Academy of Pediatrics and the Children's Hospital Association, in agreement with the data provided by the CDC. As their results indicate, approximately 7.8% of the newborns from tested COVID-positive mothers showed a positive PCR test at birth [2] . These small numbers of neonates with COVID-19 infection were confirmed by a study from Wuhan, China, where only three cases were reported out of a total of 33 pregnant women, with an infection rate of 9.09% [3] . In most of the cases, the newborns developed an asymptomatic or mild form of infection [4] . It is a fact that lung ultrasonography (LUS) has the great advantage of being easy to use; it is safe and non-invasive for infants, and at the same time, it is a useful method in the management of pulmonary and cardiac diseases in neonates. Lung artifacts detected by ultrasonography vary slightly with age, so it may be suitable for neonatal respiratory pathology, especially in the SARS-CoV-2 infection [5] [6] [7] . A number of studies demonstrate the usefulness of LUS in the evaluation of COVID -19-associated lung lesions in children, indicating that LUS sensitivity was higher than in the case of CT and CXR. Even if CT images present the highest accuracy, CT should not always be recommended for all children with COVID due to its significant irradiation potential. Furthermore, recent studies demonstrated a strong correlation between LUS and CT scores, proving that an ultrasound score higher than 20 (using 12-area score) is associated with an increased risk of complications and death [8, 9] . As COVID-19 has become a worldwide disease, in many hospitals, the availability of CT scans for many patients diagnosed with COVID-19 is not widespread. Chest X-rays are more readily available, but they lack the necessary specificity and sensitivity for detecting COVID-19 pneumonia so as to be considered a reliable substitute method for CT scans [10] . Recent studies show the usefulness of LUS in detecting COVID-19, especially for pneumonia detection [11, 12] . The findings concerning lung ultrasound procedures in the diagnostic assessment of children with COVID pneumonia are similar to the ones described in the case of adults and children with other types of pneumonia [13, 14] . Lung ultrasound showed its utility in many other neonatal respiratory diseases, such as respiratory distress syndrome, transient tachypnea of the newborn, pneumonia, meconium aspiration syndrome, pulmonary hemorrhage and atelectasis of the newborn, pneumothorax, and so on [15, 16] . Therefore, the aim of this review is to evaluate the utility of LUS for newborns diagnosed with COVID-19. For the current literature review, the PubMed and ScienceDirect databases were searched, with a focus on articles written in English between December 1st 2019 and November 4th 2021. The articles were selected by searching the PRISMA tool (preferred reporting items for systematic reviews and meta-analyses), and in accordance with this, a systematic literature review was conducted. A total of 81 articles published between December 1st 2019 and November 4th 2021, covering the COVID period, were found involving the MeSH Terms (("Ultrasonography"[Mesh]) AND "Lung"[Mesh]) AND "Infant, Newborn" [Mesh] . After this process, only seven articles were included and discussed in this study, according to the below-mentioned criteria. The articles under scrutiny were selected according to the following criteria: -Pathology: COVID-19 pneumonia, SARS-CoV-2 infection; -Intervention/tool: lung ultrasound; -Age/population of interest: newborns, neonates, infants,